These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 11087205

  • 21. Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.
    Carmenate T, Guirola M, Alvarez A, Canaán L, González S, Caballero E, Menéndez T, Guillén G.
    FEMS Immunol Med Microbiol; 2005 Feb 01; 43(2):133-40. PubMed ID: 15681142
    [Abstract] [Full Text] [Related]

  • 22. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q, Lakshman R, Burkinshaw R, Choo S, Everard J, Akhtar S, Finn A.
    Infect Immun; 2001 Jul 01; 69(7):4337-41. PubMed ID: 11401971
    [Abstract] [Full Text] [Related]

  • 23. Prevention of meningococcal serogroup C disease by NeisVac-C.
    Borrow R, Findlow J.
    Expert Rev Vaccines; 2009 Mar 01; 8(3):265-79. PubMed ID: 19249967
    [Abstract] [Full Text] [Related]

  • 24. Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?
    Tsai TF, Borrow R, Gnehm HE, Vaudaux B, Heininger U, Desgrandchamps D, Aebi C, Balmer P, Pedersen RD, Fritzell B, Siegrist CA.
    Clin Vaccine Immunol; 2006 Aug 01; 13(8):854-61. PubMed ID: 16893984
    [Abstract] [Full Text] [Related]

  • 25. Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children.
    Nurkka A, MacLennan J, Jäntti V, Obaro S, Greenwood B, Käyhty H.
    Vaccine; 2000 Oct 15; 19(4-5):547-56. PubMed ID: 11027820
    [Abstract] [Full Text] [Related]

  • 26. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE, Halperin SA, Law BJ, Forrest B, Danzig LE, Granoff DM.
    JAMA; 1998 Nov 18; 280(19):1685-9. PubMed ID: 9832000
    [Abstract] [Full Text] [Related]

  • 27. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A, Read RC.
    Expert Rev Vaccines; 2011 Mar 18; 10(3):335-43. PubMed ID: 21434801
    [Abstract] [Full Text] [Related]

  • 28. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.
    Halperin SA, McDonald J, Samson L, Danzig L, Santos G, Izu A, Smith B, MacDonald N.
    Clin Invest Med; 2002 Dec 18; 25(6):243-51. PubMed ID: 12516995
    [Abstract] [Full Text] [Related]

  • 29. Reconsideration of the use of meningococcal polysaccharide vaccine.
    Granoff DM, Pollard AJ.
    Pediatr Infect Dis J; 2007 Aug 18; 26(8):716-22. PubMed ID: 17848884
    [Abstract] [Full Text] [Related]

  • 30. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 18; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [Abstract] [Full Text] [Related]

  • 31. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination.
    Trotter CL, Gay NJ, Edmunds WJ.
    Am J Epidemiol; 2005 Jul 01; 162(1):89-100. PubMed ID: 15961591
    [Abstract] [Full Text] [Related]

  • 32. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial.
    MacLennan JM, Shackley F, Heath PT, Deeks JJ, Flamank C, Herbert M, Griffiths H, Hatzmann E, Goilav C, Moxon ER.
    JAMA; 2000 Jun 07; 283(21):2795-801. PubMed ID: 10838647
    [Abstract] [Full Text] [Related]

  • 33. Antibody persistence 12 months after a booster dose of meningococcal-C conjugated vaccine in the second year of life.
    Diez-Domingo J, Planelles-Cantarino MV, Baldo-Torrenti JM, Ubeda-Sansano I, Jubert-Rosich A, Puig-Barbera J, Gutierrez-Gimeno MV.
    Pediatr Infect Dis J; 2010 Aug 07; 29(8):768-70. PubMed ID: 20375851
    [Abstract] [Full Text] [Related]

  • 34. Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers.
    Findlow H, Sow S, Borrow R, Tapia M, Haidara FC, Akinsola AK, Idoko OT, Diallo F, Adegbola R, Tang Y, Parulekar V, Chadha H, Mabey L, Holme D, Townsend K, Chaumont J, Laforce FM, Kulkarni PS, Marchetti E, Viviani S, Hassan-King M, Preziosi MP.
    Clin Vaccine Immunol; 2011 Sep 07; 18(9):1492-6. PubMed ID: 21752951
    [Abstract] [Full Text] [Related]

  • 35. Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age.
    Tejedor JC, Moro M, Merino JM, Gómez-Campderá JA, García-del-Rio M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Ruiz-Contreras J, Martin-Ancel A, Roca J, Boceta R, García-Corbeira P, Maechler G, Boutriau D, Spanish 102547 Study Group.
    Pediatr Infect Dis J; 2008 Jul 07; 27(7):579-88. PubMed ID: 18536619
    [Abstract] [Full Text] [Related]

  • 36. Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults.
    de Voer RM, van der Klis FR, Engels CW, Schepp RM, van de Kassteele J, Sanders EA, Rijkers GT, Berbers GA.
    Vaccine; 2009 Nov 23; 27(50):6974-82. PubMed ID: 19800445
    [Abstract] [Full Text] [Related]

  • 37. Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial.
    Hirve S, Bavdekar A, Pandit A, Juvekar S, Patil M, Preziosi MP, Tang Y, Marchetti E, Martellet L, Findlow H, Elie C, Parulekar V, Plikaytis B, Borrow R, Carlone G, Kulkarni PS, Goel A, Suresh K, Beri S, Kapre S, Jadhav S, Preaud JM, Viviani S, LaForce FM.
    Vaccine; 2012 Oct 05; 30(45):6456-60. PubMed ID: 22898557
    [Abstract] [Full Text] [Related]

  • 38. Priming for immunologic memory in adults by meningococcal group C conjugate vaccination.
    Vu DM, de Boer AW, Danzig L, Santos G, Canty B, Flores BM, Granoff DM.
    Clin Vaccine Immunol; 2006 Jun 05; 13(6):605-10. PubMed ID: 16760316
    [Abstract] [Full Text] [Related]

  • 39. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
    Slack MH, Schapira D, Thwaites RJ, Burrage M, Southern J, Andrews N, Borrow R, Goldblatt D, Miller E.
    J Infect Dis; 2001 Dec 15; 184(12):1617-20. PubMed ID: 11740740
    [Abstract] [Full Text] [Related]

  • 40. B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody.
    Perrett KP, Jin C, Clutterbuck E, John TM, Winter AP, Kibwana E, Yu LM, Curtis N, Pollard AJ.
    J Immunol; 2012 Sep 01; 189(5):2673-81. PubMed ID: 22855707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.